Changchun Genescience Pharmaceutical Co., Ltd.

This early-stage trial tested a new drug called gentulizumab in people with acute myeloid leukemia or myelodysplastic syndrome that had returned or stopped responding to standard treatments. The drug works by blocking a protein (CD47) that cancer cells use to hide from the immune…

This study tested a new oral drink (GS3-007a) to diagnose adult growth hormone deficiency (AGHD). It compared the drink to the standard insulin tolerance test in 120 adults suspected of having AGHD and healthy volunteers. The goal was to see if the oral test works as well as the …